MarketPulse — Real-Time Financial News & Market Analysis

Federal court approves $1.6M class action settlement for Cummins investors. Settlement fairness hearing scheduled May 2026; claim deadline April 23, 2026.

Google AI Overviews criticize brands 44% more than ChatGPT, with divergent placement causing revenue risk for marketers.

Portnoy Law Firm investigates Danone for securities fraud following infant formula contamination, with stock falling 10.65% over two trading days.

Vera Therapeutics appoints Christopher Hite, Royalty Pharma EVP, to board as the biotech prepares for atacicept launch in IgA nephropathy treatment.

Pan American Silver discovers four new high-grade veins at La Colorada mine with exceptional silver assays, though shares decline 1.87% despite positive exploration results.

JS Global pivots from SharkNinja reliance to Asia-Pacific focus, posting 86.9% regional growth despite $22.5M net loss from non-operating costs.

Meros Investment Management sold 396,804 shares of Photronics in Q4 2025, cashing in $10 million in gains after stock surged 74.2% annually.

BlackSky secures seven-figure NGA contract renewal for four years, leveraging AI satellite analytics monitoring 14M sq km of global military and economic facilities.

China's narrowed 2026 subsidies spur shift toward AI-enabled consumer electronics, with premium products capturing 60% of sales despite rising material costs.

Regeneron and Vertex Pharmaceuticals emerge as compelling 2026 biotech investments, with REGN valued at 17x and VERX at 24x forward earnings, offering growth and stability respectively.

Palantir Technologies ($PLTR) delivers impressive 70% YoY revenue growth and 137% U.S. commercial growth, but 100x forward earnings valuation demands sustained excellence to justify current pricing.

Broadcom shares jump 7% after CEO signals clear visibility to $100B AI chip revenue by 2027, up from $20B in 2025, with major tech partnerships secured.

Constellation Energy surges 17.5% in February on strong Q4 earnings and 380 MW data center power deal, with Calpine acquisition driving immediate growth synergies.

CanSino reports 26% growth and profitability rebound on meningitis vaccine success, but faces concentration risk and rising competitive threats in China's declining vaccine market.

Collegium Pharmaceutical to present real-world clinical data on pain medication BELBUCA at major medical conference in March 2026.

Aligos reports $24.2M net loss in 2025, down 82% YoY. Key hepatitis B study enrollment complete; cash runway extends to Q3 2026.

ZenaTech subsidiary develops gas-powered maritime drone interceptor to counter aerial threats at fraction of conventional missile costs. Testing expected before year-end.

Aduro Clean Technologies to present investor updates on pilot operations and Hydrochemolytic™ technology commercialization at the March 2026 ROTH Conference in California.

Locafy expands Localizer platform with 165 State Farm agents across all 50 states, bolsters U.S. operations with new COO and St. Louis headquarters.

$YDDL completes San Rafael facility upgrade targeting 30%+ capacity gains and 8-12% margin expansion in precious metal recovery.